Dosing regimen
AssigneesViiv Healthcare UK (No. 7) Limited, Halozyme, Inc.
InventorsKelong HAN, Andrew Weber, Michael James Labarre, Jessica Brehm, Nima Akhavein, Emile Velthuisen
Life of this patent
Estimating the term…
Abstract
Provided are combination dosing regimens comprising administering cabotegravir and hyaluronidase. Combinations and compositions containing the cabotegravir and hyaluronidase are provided. The dosing regimens and combinations are for treating or preventing Human Immunodeficiency Virus (HIV) infection.
Claims36
A combination dosing regimen, comprising:
- administering a soluble hyaluronidase;
- and
- administering a suspension of cabotegravir.
A combination, comprising a soluble hyaluronidase and a suspension comprising cabotegravir.
A composition, comprising a soluble hyaluronidase and a suspension comprising cabotegravir.
A multi-compartment container, comprising a suspension comprising cabotegravir in one compartment, and a soluble hyaluronidase in a second compartment.
Dependencies are inferred from the claim text.